Skip to main content
. Author manuscript; available in PMC: 2021 Jul 1.
Published in final edited form as: Thromb Res. 2020 Apr 23;191:42–49. doi: 10.1016/j.thromres.2020.03.025

Table 5.

Multivariable Predictive Model (white lines) and Internal Validation Model (gray lines) using Table 3 (inclusive of thromboembolic disorder)

Predictor Variable Adjusted OR (95% CI) p-value
Mode of delivery (cesarean vs vaginal delivery) 1.90 (1.23 – 2.95) 0.004*
1.91 (1.84 – 1.99) <0.001*
BMI (admission) per 5 unit increase 1.25 (1.08 – 1.43) 0.002*
1.23 (1.21 – 1.24) <0.001*
Pre-gestational diabetes 3.37 (1.75 – 6.48) <0.001*
3.41 (3.21 – 3.61) <0.001*
Chronic heart disease 3.27 (1.45 – 7.37) 0.004*
3.25 (3.02 – 3.49) <0.001*
Preeclampsia 2.03 (1.21 – 3.40) 0.011*
1.99 (1.90 – 2.09) <0.001*
Blood transfusion (intrapartum or postpartum) 3.29 (1.74 – 6.22) <0.001*
3.30 (3.12 – 3.50) <0.001*
Prenatal history of thromboembolic disorder 140.00 (85.20 – 232.00) <0.001*
141.45 (135.26 – 147.91) <0.001*
Postpartum maternal length of stay, per 1 day increase 1.06 (1.04 – 1.09) <0.001*
1.06 (1.06 – 1.07) <0.001*
*

p<.05, statistically significant